Alumis

Senior Scientist I Analytical Development

Alumis  •  $112k - $135k/yr  •  South San Francisco, CA (Remote)  •  18 days ago
Apply
AI can make mistakes so check important info. Chat history is never stored.
41
AI Success™

Job Description

Alumis Inc. is a precision medicines company with the mission to transform the lives of patients with autoimmune diseases. Even with treatment innovations of the last two decades, many patients with immunologic conditions continue to suffer - our goal is to fundamentally change the outcomes for these patients.

ThesmallmoleculeCMCteamisseekinghighlymotivatedSr. ScientistI ofAnalyticalDevelopmenttohelpbuildourdynamicsmallmolecule CMCgroupatAlumisThe successful candidate will help to support theanalytical development and quality control activities from the preclinical phase through late-stage clinical development. Having analytical developmentexpertise and experience in working with CMOs/CTLs, coupled with thoroughunderstanding of the associated quality and regulatory awareness are key assets.

RESPONSIBILITIES

  • Support development, validation, and transfer of analytical methods to support starting material, intermediate, drug substance and drug product testing at CMOs/CTLs
  • Execute and/or support the in-house method development activities using UPLC/HPLC, LC-MS, KF, and dissolution instrumentation and techniquesfor Phase 1 to late-stage drug development
  • Review CMO/CTL analytical data (in-process, release, and stability data), protocols and reports
  • Trend stability and release data using statistical methods
  • Assist in investigation for various non-conformance events at CMOs/CTLs
  • Collaborate with CMC team, QA and CMOsCTLs towards timely generation and approval of documents
  • Communicate scientific results (oral and written) in a clear and concise manner within cross-functional teams
  • Author technical reports and documents in support of regulatory filing
  • Assist in preparation of CMC documents for regulatory submissions (IND, IMPD, and/or NDA)

THE IDEAL CANDIDATE

  • BS/MSinchemistryor pharmaceutical sciences with5+yearsofexperienceinanalytical development
  • Experience with analytical techniques for small drug molecules and oral solid formulations required, including UPLC/HPLC, LC-MS, KF, dissolution testing, IR, particle size analysis, and solid-state characterization techniques
  • Proven track record in applying analytical techniques to solve challenging problems
  • Experience in working with CMOs and CTLs
  • Experience in early to late-stage drug development
  • Strong organizational and communication skills
  • Comfortable in a fast-paced small company environment and a strong team player
  • Experience and knowledge in ICH, cGMP and regulatory requirements

This position is located in South San Francisco, CA. At this time, we are not considering fully remote applicants.

The salary range for this position is $112,000 USD to $135,000 USD annually. This salary range is an estimate, and the actual salary may vary based on the Company’s compensation practices.

Alumis Inc. is an equal opportunity employer.

Alumis compensation packages include generous stock option grants for all employees as well as an annual bonus program.

Other benefits include:

  • Health insurance premiums paid at 90% for employee, 80% for dependents
  • Free access to Genentech Bus & Ferry Share program
  • $100 monthly cell phone stipend
  • Unlimited PTO for Exempt employees
  • Free onsite gym and a kitchen stocked with yummy snacks and drinks!

We are a hard-working, collaborative team on a mission to transform patient’s lives-- and we aspire to elevate, challenge and nurture one another along the way.

Alumis

About Alumis

At Alumis, our goal is to significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies.

We recognize that patients living with immune-mediated diseases need alternatives to currently available therapies. Despite recent advances and innovations in the treatment of immune-mediated diseases, many patients continue to suffer, cycling through currently approved therapies while looking for a solution that alleviates the debilitating impact of their disease without life-limiting side effects.

Addressing the needs of these patients is why we exist. We are pioneering a precision approach that leverages insights we derive from powerful data analytics to select the right target, right molecule, right indication, right patient, and right endpoint resulting in optimized outcomes for patients. We believe that combining our insights with an integrated approach to drug development will produce the next generation of treatments to address immune dysfunction.

Incubated by Foresite Labs, Alumis is led by a team of deeply experienced professionals who are devoted to transforming the lives of patients with immune-mediated diseases by developing a pipeline of transformative therapies.

Industry
Biotech & Life Sciences
Company Size
201-500 employees
Headquarters
South San Francisco, California
Year Founded
2021
Social Media